LRIG1 and carcinoma: However, EGF signaling must be controlled discreetly, since ablation of leucine rich repeats and immunoglobulin like domains 1 (Lrig1), an ISC marker and negative regulator of EGFR, induces ISC expansion or even duodenal adenomas and superficially invasive carcinomas in mice (112, 114).